A Clinical Feasibility Study of the Aquea Intracanalicular Glaucoma Micro-coil Stent
NCT: NCT07698353 · ACTIVE_NOT_RECRUITING
Brief Summary
The purpose of this research study is to evaluate the safety and effectiveness of the Aquea Intracanalicular Glaucoma Stent in lowering intraocular pressure (IOP) in patients with cataract and open angle glaucoma. The main questions it aims to answer are: * What proportion of eyes will have a ≥ 20% decrease in IOP from the hypotensive medication-free baseline examination to the hypotensive medication-free 12-month postoperative examination. * What is the mean change in IOP between the hypotensive medication-free baseline examination and hypotensive medication-free 12-month postoperative examination. Participants will be screened for eligibility. * Eligible subjects will be examined preoperatively to obtain a medical history and to establish a baseline for their ocular condition. * Subjects will undergo implantation of the Aquea Intracanalicular Glaucoma Stent in one eye in conjunction with cataract surgery. * Postoperatively, subjects will undergo evaluation at regularly scheduled intervals.
Frequently Asked Questions
What is A Clinical Feasibility Study of the Aquea Intracanalicular Glaucoma Micro-coil Stent?
A Clinical Feasibility Study of the Aquea Intracanalicular Glaucoma Micro-coil Stent is a clinical trial registered under NCT07698353. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT07698353?
The current status of NCT07698353 (A Clinical Feasibility Study of the Aquea Intracanalicular Glaucoma Micro-coil Stent) is: ACTIVE_NOT_RECRUITING.
When did A Clinical Feasibility Study of the Aquea Intracanalicular Glaucoma Micro-coil Stent start?
A Clinical Feasibility Study of the Aquea Intracanalicular Glaucoma Micro-coil Stent started on 2024-04-17.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.